Waymo Steps Into Paid Autonomy: To Begin Charging For San Francisco Rides

Alphabet Inc‘s (NASDAQ:GOOG) (NASDAQ:GOOGL) autonomous driving tech unit Waymo will start charging for rides across San Francisco starting Monday,…

Alphabet Inc‘s (NASDAQ:GOOG) (NASDAQ:GOOGL) autonomous driving tech unit Waymo will start charging for rides across San Francisco starting Monday, days after California greenlighted its service expansion.

What Happened: Pricing will be ‘competitive’ and ‘reasonable,’ a company spokesperson told Benzinga. Riders will be shown an estimated cost for their trip before accepting and it will be based on time and distance.

“During busier times, like nights and weekends, prices may be higher,” they said, hinting it will deploy surge pricing. However, the price will be based on the most direct route and will not change even if the vehicle reroutes.

The company has already informed its public riders via mail about this transition, the spokesperson said.

Why It Matters: Waymo and General Motors‘ Cruise received driverless deployment permit for 24×7 fared operation in San Francisco from the California Public Utilities Commission on Aug. 10. “With over 100,000 signups (and counting) on our waitlist, we expect demand will be incredibly high,” Waymo said in a statement on Friday after receiving the permit.

Until then, autonomous vehicle rides were available only in parts and during certain hours of the day. Waymo was mostly offering free service to customers in San Francisco.

Photo Courtesy: Shutterstock.com

Check out more of Benzinga’s Future Of Mobility coverage by following this link.

Read More: Elon Musk’s SpaceX On Track To Lift 80% Of World’s Space Payload — Surpassing China’s Orbit Delivery By 8-Fold

Total
0
Shares
Related Posts
Read More

Cannabis Stocks And ETFs Trading Higher As Government Recommendations Ignite Hope For Industry

Cannabis stocks and ETFs opened higher on Tuesday following the release of documents related to the Department of Health and Human Service's (HHS) review of cannabis. Investors are optimistic about potential regulatory changes that could benefit the cannabis industry after the US government released 252 pages of documents confirming the HHS's recommendation that the DEA reschedule cannabis as Schedule III under the Controlled Substances Act. The documents state that cannabis has a currently accepted medical use in treatment and potential for abuse less than drugs in Schedules I and II. In August, the Assistant Secretary for Health wrote a letter to the DEA calling for marijuana to be reclassified. The Secretary of HHS has confirmed that his department shared a comprehensive scientific review with the DEA in response to President Joe Biden's scheduling directive.

ACB